Henlix Biotech has been awarded the 13th National Award.

Henlix Biotech has been awarded the 13th National Award for Development and Application of an Innovative Monoclonal Antibody HLX07 for Cancer Therapy in the Pharmaceutical and New Medical Technology Category by the Institute for Biotechnology and Medicine Industry.

回列表